Home Sectors Healthcare Love or Hate: U.S. Physical Therapy (NYSE: USPH)

Love or Hate: U.S. Physical Therapy (NYSE: USPH)

30
0
SHARE

U.S. Physical Therapy is in the healthcare sector and is in the health care providers industry. The company CEO is Christopher J. Reading. US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics across US which provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries.

Previous Intraday Trading Performance:

The USPH stock showed a previous change of -0.54% with an open at 108.81 and a close of 108.45. It reached an intraday high of 109.78 and a low of 107.66.

Business Wire:  U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year End 2018 Release and Conference Call for Thursday, March 7, 2019

Liquidity:

The stock has a market cap of $1.4b with 12.7m shares outstanding, of which the float is 12.1m shares. Trading volume reached 99,346 shares compared to its average volume of 87,979 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, U.S. Physical Therapy shares returned 1.99% and in the past 30 trading days it returned 6.08%. Over three months, it changed 1.72%. In one year it has changed 42.44% and within that year its 52-week high was 129.65 and its 52-week low was 71.70. USPH stock is 51.26% above its 52 Week Low.

Our calculations show a 200 day moving average of 106.64 and a 50 day moving average of 108.09. Currently USPH stock is trading 1.70% above its 200 day moving average and may be a good opportunity to buy.

Business Wire:  U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year End 2018 Release and Conference Call for Thursday, March 7, 2019

Earnings:

The last annual fiscal EPS for the company was reported at 1.75 that ended on 31st of December 2017, which according to the previous close, that is a PE of 61.97. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.63. The TTM EPS is 2.42, which comes to a TTM PE of 44.81. Historically, the PE high was 61.97 and the PE low was 15.10. If the stock reached its PE low, that would represent a price of 36.55, which is a decrease of -66.30%.

The following are the last four quarter reported earnings per share:
09-30-2018:  0.64
06-30-2018:  0.73
03-31-2018:  0.56
12-31-2017:  0.49

The dividend per share is currently 0.92, which is a dividend yield of 0.85%. Also, the payout ratio is 38.02%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 98.59, which means it may be overvalued by -10.00%

Indicators to Watch:

Based on the latest filings, there is 150.90% of institutional ownership. Short-interest is 1,163,734, which is 9.17% of shares outstanding. The short-interest ratio or days-to-cover ratio is 9.59. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.

The current calculated beta is 1.14

CNBC:  Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & more

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 9.04%, return on assets is 4.28%, profit margin is 11.35%, price-to-sales is 4.46 and price-to-book is 6.37.

Company Scores:

All scores are out of six:
 0  :Valuation Score
 1  :Past Performance Score
 5  :Financial Strength Score
 2  :Future Growth Score
 1  :Dividend Score
 1  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.